论文部分内容阅读
1996年8月～1999年12月,我院神经内科使用金钠多注射液治疗急性脑梗死患者120例并与对照组(D-40+复方丹参注射液组)96例进行对照观察,现报告如下。1 资料与方法1.1 一般资料观察组120例,男76例,女44例,年龄44～82岁,平均年龄62.5岁,有高血压病史72例,2型糖尿病史40例,高脂血症45例。对照组96例,男55例,女41例,年龄43～80岁,平均61.8岁,有高血压病史42例,2型糖尿病史30例,高脂血症38例。两组病例均为脑梗死起病72小时
From August 1996 to December 1999, 120 cases of patients with acute cerebral infarction were treated with Jindongduo injection in our department of neurology, and 96 cases were compared with 96 cases of control group (D-40 + Danshen injection group) as follows. 1 Materials and Methods 1.1 General Information 120 cases of observation group, 76 males and 44 females, aged 44 to 82 years, mean age 62.5 years, 72 cases of history of hypertension, type 2 diabetes history of 40 cases of hyperlipidemia 45 example. The control group of 96 patients, 55 males and 41 females, aged 43 to 80 years, mean 61.8 years, 42 cases of history of hypertension, type 2 diabetes mellitus history of 30 cases, 38 cases of hyperlipidemia. Two groups of patients were onset of cerebral infarction for 72 hours